Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
RA patients are enrolling in a clinical study from StemGenex that looks to harness the power of patient-specific, adipose-derived mesenchymal stem cells (MSCs) for their anti-inflammatory and potentially therapeutic ... Read more
As science and medicine evolve over time, rheumatoid arthritis (RA) patients are experiencing an increase in quality of life from improved disease prognosis. In large part, advances in treatment ... Read more
Rituximab was shown to be a cost-effective second-line treatment for individuals with rheumatoid arthritis in a recent article from University Hospital Santa Maria della Misericordia in Italy. A team ... Read more
Biogen and Samsung Bioepis Co., Ltd. have three exciting new anti-tumor necrosis factor (anti-TNF) biosimilars under development to treat patients with rheumatoid arthritis. Representatives from the companies will present data ... Read more
The discovery of a new pathway involved in immunity may help alleviate rheumatoid arthritis and other inflammatory diseases. A group of researchers from University of Birmingham led by Professor ... Read more
Although rheumatoid arthritis and osteoarthritis are two very unique and separate diseases, a team of researchers at Duke Medicine discovered that a rheumatoid arthritis drug can limit the development ... Read more
Pin It on Pinterest